Company Filing History:
Years Active: 2022
Title: The Innovations of Todd L Graybill
Introduction
Todd L Graybill is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate the stimulator of interferon genes (STING). His work has the potential to impact therapeutic approaches in various diseases.
Latest Patents
Todd L Graybill holds 1 patent for his invention titled "Modulators of stimulator of interferon genes (STING)." This patent discloses compounds characterized by a specific formula, which includes various defined components and their tautomeric forms or salts, particularly pharmaceutically acceptable salts.
Career Highlights
Graybill is associated with GlaxoSmithKline Intellectual Property Development Limited, where he has been instrumental in advancing innovative solutions in the pharmaceutical sector. His expertise in the field has led to the development of novel compounds that could enhance therapeutic efficacy.
Collaborations
Throughout his career, Todd has collaborated with notable colleagues, including David T Fosbenner and Jianxing Kang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Todd L Graybill's contributions to the field of biotechnology exemplify the impact of innovative thinking in developing new therapeutic strategies. His work continues to inspire advancements in medical research and development.